Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varicella vaccine in patients receiving TNF-alpha inhibitors
jRCTs031210428Completed
- Sponsor
- A grant from the National Center for Child Health and Development (2021B-9)
- Start
- Nov 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of varicella vaccine, live in chickenpox and Varicella zoster infection, sponsored by A grant from the National Center for Child Health and Development (2021B-9). Primary endpoint: Presence or absence of vaccine-strain varicella. Started Nov 2021; status: completed.
02
Drugs
varicella vaccine, live
03
Conditions
chickenpoxVaricella zoster infection
Beyond the preview
Go deeper on jRCTs031210428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031210428.